SDHA Inhibitors

SDHA inhibitors are chemicals that either directly interact with the SDHA subunit of succinate dehydrogenase (complex II) or modulate its activity indirectly by affecting related metabolic pathways. Direct inhibitors like malonate and 3-nitropropionic acid bind to the active site of SDHA, mimicking or blocking its natural substrate, succinate, thereby inhibiting its function in the electron transport chain. Other inhibitors such as thenoyltrifluoroacetone (TTFA) and atpenin A5 target the ubiquinone binding site in complex II, disrupting the transfer of electrons from SDHA to ubiquinone, which is a crucial step in mitochondrial respiration.

Indirect inhibitors like oxaloacetate and phenylsuccinate compete with succinate at the active site of SDHA, affecting its catalytic activity. Compounds like itaconate and dimethyl malonate inhibit SDH activity, impacting mitochondrial metabolism and energy production. Additionally, inhibitors like sodium fluoroacetate and methylenecyclopropylglycine exert their effects by disrupting upstream processes in the Krebs cycle, indirectly affecting the availability of substrates necessary for SDHA function. Dichloroacetate, although not a direct inhibitor, can influence the metabolic flux through the Krebs cycle, impacting SDHA activity. These inhibitors collectively demonstrate how targeting different aspects of mitochondrial function and cellular metabolism can modulate the activity of key enzymes like SDHA. By inhibiting SDHA, these chemicals can have profound effects on mitochondrial respiration and energy production, highlighting the enzyme's critical role in cellular metabolism.